• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆管癌以及放疗和化疗的作用

Cholangiocarcinoma and the role of radiation and chemotherapy.

作者信息

Price P

机构信息

Department of Cancer Therapeutics, ICSM Academic, Department of Radiation Oncology, Christie Hospital, Manchester, England.

出版信息

Hepatogastroenterology. 2001 Jan-Feb;48(37):51-2.

PMID:11268997
Abstract

Cholangiocarcinoma is a rare tumor. Many cases are localized while metastatic disease within the liver and abdomen do occur. There is as yet no standard therapy for advanced bile duct tumors. Radiotherapy and chemotherapy are not curative modalities in this condition but are being assessed adjuvantly following surgery, and as palliative treatment in an attempt to either extend progression-free and overall survival or to palliate symptoms. Advances may be made by: (i) The combined use of radiation and chemotherapy, (ii) High dose conformal radiotherapy, (iii) Novel chemotherapeutic agents. Patients should be given the opportunity to participate in clinical trials.

摘要

胆管癌是一种罕见的肿瘤。许多病例为局限性,但肝内和腹腔内的转移性疾病确实会发生。对于晚期胆管肿瘤,目前尚无标准治疗方法。放疗和化疗在此种情况下并非根治性手段,但正在评估其在手术后作为辅助治疗以及作为姑息治疗的效果,以期延长无进展生存期和总生存期或缓解症状。可通过以下方式取得进展:(i)放疗与化疗联合使用,(ii)高剂量适形放疗,(iii)新型化疗药物。应给予患者参与临床试验的机会。

相似文献

1
Cholangiocarcinoma and the role of radiation and chemotherapy.胆管癌以及放疗和化疗的作用
Hepatogastroenterology. 2001 Jan-Feb;48(37):51-2.
2
Arterial chemotherapy and conformal radiation abolish malignant biliary obstruction.动脉化疗和适形放疗可消除恶性胆管梗阻。
Integr Cancer Ther. 2008 Mar;7(1):51-3. doi: 10.1177/1534735408314093.
3
The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.胃肠道癌的多学科管理。胆管癌:从发病机制到内镜治疗。
Best Pract Res Clin Gastroenterol. 2007;21(6):1015-29. doi: 10.1016/j.bpg.2007.09.005.
4
Diagnosis and management of cholangiocarcinomas: a comprehensive review.胆管癌的诊断与管理:全面综述
Hepatogastroenterology. 2004 Jan-Feb;51(55):43-50.
5
Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.不可切除性肝内胆管癌放疗作用的探讨:75例患者的回顾性分析
Cancer J. 2006 Mar-Apr;12(2):113-22.
6
[Diagnostics and treatment of cholangiocarcinoma].[胆管癌的诊断与治疗]
Ned Tijdschr Geneeskd. 2008 May 3;152(18):1037-41.
7
Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.高剂量适形放射治疗联合肝动脉氟尿苷治疗不可切除肝内恶性肿瘤的II期试验。
J Clin Oncol. 2005 Dec 1;23(34):8739-47. doi: 10.1200/JCO.2005.01.5354.
8
Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions.切除术后肝外胆管癌的辅助治疗:文献综述与未来方向
Cancer Treat Rev. 2009 Jun;35(4):322-7. doi: 10.1016/j.ctrv.2008.11.009. Epub 2009 Jan 14.
9
Role of liver transplantation in the treatment of cholangiocarcinoma.肝移植在胆管癌治疗中的作用。
Expert Rev Anticancer Ther. 2009 Apr;9(4):491-502. doi: 10.1586/era.09.5.
10
Eleven-year survivor of unresectable intrahepatic cholangiocarcinoma treated using long-term UFT therapy.一位使用长期优福定治疗的无法切除的肝内胆管癌患者存活了11年。
Hepatogastroenterology. 2008 Nov-Dec;55(88):1997-9.

引用本文的文献

1
Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index.晚期胆管癌患者的预后因素:手术、化疗及体重指数的作用
World J Gastroenterol. 2008 May 28;14(20):3224-30. doi: 10.3748/wjg.14.3224.
2
Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy.吉西他滨肝动脉内化疗治疗不可切除胆管癌和胰腺癌肝转移患者:最大耐受剂量及治疗疗效的临床研究
J Cancer Res Clin Oncol. 2006 Nov;132(11):745-55. doi: 10.1007/s00432-006-0138-0. Epub 2006 Jul 21.
3
The tumor-selective viral protein apoptin effectively kills human biliary tract cancer cells.
肿瘤选择性病毒蛋白凋亡素可有效杀死人胆管癌细胞。
J Mol Med (Berl). 2004 Jan;82(1):56-63. doi: 10.1007/s00109-003-0486-z. Epub 2003 Nov 28.